Professor Karen Canfell

Adjunct Professor in the School of Public Health
Director, Cancer Research Division, Cancer Council NSW

Telephone +61 2 9334 1852
Fax +61 2 83023550

Map

Research interests

Screening and prevention of cervical, breast and colorectal cancers.

Current research students

Project title Research student
Maximising benefits and minimizing harms in obstetric outcomes with HPV prevention Susan YUILL

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Canfell, K., Banks, E. (2010). Oral Contraceptives, Hormone Replacement Therapy, and Cancers of the Female Reproductive System. In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 111-130). London: Imperial College Press. [More Information]

Journals

  • Canfell, K. (2018). Cervical screening in HPV-vaccinated populations. Climacteric, 21(3), 227-234. [More Information]
  • Wade, S., Weber, M., Caruana, M., Kang, Y., Marshall, H., Manser, R., Vinod, S., Rankin, N., Fong, K., Canfell, K. (2018). Estimating the cost-effectiveness of lung cancer screening with low dose computed tomography for high risk smokers in Australia. Journal of Thoracic Oncology, 13(8), 1094-1105. [More Information]
  • Lew, J., St John, D., Macrae, F., Emery, J., Ee, H., Jenkins, M., He, E., Grogan, P., Caruana, M., Sarfati, D., Canfell, K., et al (2018). Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. International Journal of Cancer, 143(2), 269-282. [More Information]
  • He, E., Lew, J., Egger, S., Banks, E., Ward, R., Beral, V., Canfell, K. (2018). Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. Preventive Medicine, 106, 185-193. [More Information]
  • Nair-Shalliker, V., Bang, A., Weber, M., Goldsbury, D., Caruana, M., Emery, J., Banks, E., Canfell, K., O'Connell, D., Smith, D. (2018). Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study. Scientific Reports, 8(1), 4261. [More Information]
  • Goldsbury, D., Yap, S., Weber, M., Veerman, L., Rankin, N., Banks, E., Canfell, K., O'Connell, D. (2018). Health services costs for cancer care in Australia: Estimates from the 45 and Up Study. PloS One, 13(7), 1-15. [More Information]
  • Xu, H., Egger, S., Velentzis, L., O'Connell, D., Banks, E., Darlington-Brown, J., Canfell, K., Sitas, F. (2018). Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30�44 years: A case-control study in New South Wales, Australia. Cancer Epidemiology, 55, 162-169. [More Information]
  • Yap, S., Goldsbury, D., Yap, M., Yuill, S., Rankin, N., Weber, M., Canfell, K., O'Connell, D. (2018). Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: A population-based study. Lung Cancer, 122, 171-179. [More Information]
  • Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017�2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]
  • Canfell, K., Saville, M., Caruana, M., Gebski, V., Darlington-Brown, J., Brotherton, J., Heley, S., Castle, P. (2018). Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia. BMJ Open, 8(1), 1-13. [More Information]
  • Hammond, I., Canfell, K., Saville, M. (2017). A new era for cervical screening in Australia: Watch this space!. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(5), 499-501. [More Information]
  • Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J., Gertig, D., Jennett, C., Farnsworth, A., Tan, J., et al (2017). Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PLoS Medicine, 14(9), 1-21. [More Information]
  • Lew, J., Simms, K., Smith, M., Saville, M., Hammond, I., Canfell, K. (2017). Cost-effectiveness estimates: the need for complete reporting � Authors' reply. The Lancet Public Health, 2(5), e212. [More Information]
  • Wentzensen, N., Arbyn, M., Berkhof, J., Bower, M., Canfell, K., Einstein, M., Farley, C., Monsonego, J., Franceschi, S. (2017). Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice. International Journal of Cancer, 140(10), 2192-2200. [More Information]
  • Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
  • Weber, M., Yap, S., Goldsbury, D., Manners, D., Tammemagi, M., Marshall, H., Brims, F., McWilliams, A., Fong, K., Kang, Y., Canfell, K., et al (2017). Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool. International Journal of Cancer, 141(2), 242-253. [More Information]
  • Goldsbury, D., Weber, M., Yap, S., Banks, E., O'Connell, D., Canfell, K. (2017). Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study. BMC Medical Informatics and Decision Making, 17(1), 1-10. [More Information]
  • Smith, M., Edwards, S., Canfell, K. (2017). Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985�2013 in all women and in Maori women. Cancer Causes and Control, 28(12), 1393-1404. [More Information]
  • Lew, J., St John, D., Xu, X., Greuter, M., Caruana, M., Cenin, D., He, E., Saville, A., Grogan, P., Coupe, V., Canfell, K. (2017). Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: A modelling study. The Lancet Public Health, 2(7), e331-e340. [More Information]
  • Velentzis, L., Salagame, U., Canfell, K. (2017). Menopausal hormone therapy: A systematic review of cost-effectiveness evaluations. BMC Health Services Research, 17(1), 1-15. [More Information]
  • Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
  • Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]
  • Smith, M., Canfell, K. (2017). Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia. Papillomavirus Research, 3, 134-141. [More Information]
  • Arriaga, M., Vajdic, C., Canfell, K., Macinnis, R., Hull, P., Magliano, D., Banks, E., Giles, G., Cumming, R., Byles, J., Hirani, V., Mitchell, P., et al (2017). The burden of cancer attributable to modifiable risk factors: The Australian cancer-PAF cohort consortium. BMJ Open, 7(6), 1-14. [More Information]
  • Kang, Y., Smith, M., Barlow, E., Coffey, K., Hacker, N., Canfell, K. (2017). Vulvar cancer in high-income countries: Increasing burden of disease. International Journal of Cancer, 141(11), 2174-2186. [More Information]
  • Whop, L., Baade, P., Garvey, G., Cunningham, J., Brotherton, J., Lokuge, K., Valery, P., O'Connell, D., Canfell, K., Diaz, A., et al (2016). Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011. PloS One, 11(4), 1-12. [More Information]
  • Canfell, K., Saville, A., Hammond, I., Roeske, L. (2016). Changes to the cervical cancer screening program in Australia. Medicine Today, 17(5), 59-62.
  • Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
  • Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
  • Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
  • Smith, M., Canfell, K. (2016). Impact of the Australian national cervical screening program in women of different ages. Medical Journal of Australia, 205(8), 359-364. [More Information]
  • Salagame, U., Banks, E., Sitas, F., Canfell, K. (2016). Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study. International Journal of Cancer, 138(8), 1905-1914. [More Information]
  • Coffey, K., Gaitskell, K., Beral, V., Canfell, K., Green, J., Reeves, G., Barnes, I. (2016). Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women. British Journal of Cancer, 115(5), 599-606. [More Information]
  • Greuter, M., Berkhof, J., Canfell, K., Lew, J., Dekker, E., Coupe, V. (2016). Resilience of a FIT screening programme against screening fatigue: a modelling study. BMC Public Health, 16(1), 1-8. [More Information]
  • Whop, L., Garvey, G., Baade, P., Cunningham, J., Lokuge, K., Brotherton, J., Valery, P., O'Connell, K., O'Connell, D., Canfell, K., et al (2016). The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011). Cancer, 122(10), 1560-1569. [More Information]
  • Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2016). Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: Analysis of national hospital data. BMC Infectious Diseases, 16(1), 1-11. [More Information]
  • Velentzis, L., Banks, E., Sitas, F., Salagame, U., Tan, E., Canfell, K. (2016). Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study. PloS One, 11(3), 1-12. [More Information]
  • Whop, L., Diaz, A., Baade, P., Garvey, G., Cunningham, J., Brotherton, J., Canfell, K., Valery, P., O'Connell, D., Taylor, C., et al (2016). Using probabilistic record linkage methods to identify Australian Indigenous women on the Queensland Pap smear register: The national Indigenous cervical screening project. BMJ Open, 6(2), 1-10. [More Information]
  • Simms, K., Smith, M., Lew, J., Kitchener, H., Castle, P., Canfell, K. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International Journal of Cancer, 139(12), 2771-2780. [More Information]
  • Simonella, L., Canfell, K. (2015). Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries. Vaccine, 33(1), 34-51. [More Information]
  • Kang, Y., O'Connell, D., Lotocki, R., Kliewer, E., Goldsbury, D., Demers, A., Canfell, K. (2015). Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada. BMC Cancer, 15(1), 1-10. [More Information]
  • Canfell, K., Egger, S., Velentzis, L., Brown, J., O'Connell, D., Banks, E., Sitas, F. (2015). Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. Vaccine, 33(20), 2387-2394. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2015). Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data. The Journal of Infectious Diseases, 211(1), 91-99. [More Information]
  • Canfell, K. (2015). HPV vaccination and pregnancy. BMJ, 351, 1-2. [More Information]
  • Kang, Y., O'Connell, D., Tan, J., Lew, J., Demers, A., Lotocki, R., Kliewer, E., Hacker, N., Jackson, M., Delaney, G., et al (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology, 39(4), 600-611. [More Information]
  • Sitas, F., Yap, S., Egger, S., Christian, K., Hodgkinson, V., Barton, M., Banks, E., Canfell, K., O'Connell, D., Nair-Shalliker, V. (2015). The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia. Cancer Epidemiology, 39(3), 414-423. [More Information]
  • Canfell, K. (2015). Who should be vaccinated against HPV? BMJ, 350, 1-2. [More Information]
  • Simonella, L., Howard, K., Canfell, K. (2014). A survey of population-based utility scores for cervical cancer prevention. BMC Research Notes, 7(1), 1-11. [More Information]
  • Caruana, M., Kang, Y., Smith, D., O'Connell, D., Canfell, K. (2014). Estimating the benefits and harms of PSA testing in the Australian context. Cancer Forum, 38(3), 221-223.
  • Velentzis, L., Sitas, F., O'Connell, D., Darlington-Brown, J., Egger, S., Sinha, R., Banks, E., Frazer, I., Canfell, K. (2014). Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study. BMC Infectious Diseases, 14, 1-10. [More Information]
  • Smith, M., Canfell, K. (2014). Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake. PloS One, 9(8), 1-10. [More Information]
  • Smith, M., Canfell, K. (2014). Testing previous model predictions against new data on human papillomavirus vaccination program outcomes. BMC Research Notes, 7(1), 1-5. [More Information]
  • Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
  • Simonella, L., Canfell, K. (2013). Erratum to: The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England. Cancer Causes and Control, 24(11), 2035. [More Information]
  • Shafer, L., Jeffrey, I., Elias, B., Shearer, B., Canfell, K., Kliewer, E. (2013). Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model. Vaccine, 31(42), 4848-4855. [More Information]
  • Simonella, L., Canfell, K. (2013). The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England. Cancer Causes and Control, 24(9), 1727-1736. [More Information]
  • Simonella, L., Lewis, H., Smith, M., Neal, H., Bromhead, C., Canfell, K. (2013). Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infectious Diseases, 13(1), 1-10. [More Information]
  • Aminisani, N., Armstrong, B., Canfell, K. (2013). Uptake of liquid-based cytology as an adjunct to conventional cytology for cervical screening in NSW, Australia: A cross-sectional and population-based cohort analysis. BMC Public Health, 13(1), 1-7. [More Information]
  • Walker, R., Nickson, C., Lew, J., Smith, M., Canfell, K. (2012). A revision of sexual mixing matrices in models of sexually transmitted infection. Statistics in Medicine, 31(27), 3419-3432. [More Information]
  • Aminisani, N., Armstrong, B., Canfell, K. (2012). Cervical cancer screening in Middle Eastern and Asian migrants to Australia: A record linkage study. Cancer Epidemiology, 36(6), e394-e400. [More Information]
  • Legood, R., Smith, M., Lew, J., Walker, R., Moss, S., Kitchener, H., Patnick, J., Canfell, K. (2012). Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ: British Medical Journal, 345, 1-10. [More Information]
  • Shi, J., Chen, J., Canfell, K., Feng, X., Ma, J., Zhang, Y., Zhao, F., Li, R., Ma, L., Li, Z., et al (2012). Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study. BMC Health Services Research, 12(1), 1-14. [More Information]
  • Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
  • Aminisani, N., Armstrong, B., Egger, S., Canfell, K. (2012). Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia. BMC Cancer, 12(1), 1-10. [More Information]
  • Urban, M., Banks, E., Egger, S., Canfell, K., O'Connell, D., Beral, V., Sitas, F. (2012). Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African women: Case-Control study. PLoS Medicine, 9(3), 1-11. [More Information]
  • Canfell, K., Chesson, H., Kulasingam, S., Berkhof, J., Diaz, M., Kim, J. (2012). Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries. Vaccine, 30S(Supp 5), F157-F167. [More Information]
  • Shi, J., Canfell, K., Lew, J., Qiao, Y. (2012). The burden of cervical cancer in China: Synthesis of the evidence. International Journal of Cancer, 130(3), 641-652. [More Information]
  • Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
  • Canfell, K., Shi, J., Lew, J., Walker, R., Zhoa, F., Simonella, L., Chen, J., Legood, R., Smith, M., Nickson, C., et al (2011). Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29(13), 2487-2494. [More Information]
  • Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]
  • Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]
  • Canfell, K. (2010). Models of cervical screening in the era of human papillomavirus vaccination. Sexual Health, 7(3), 359-367. [More Information]
  • Canfell, K. (2010). Monitoring HPV vaccination programmes. BMJ, 340, c1666. [More Information]
  • Banks, E., Canfell, K. (2010). Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible. Breast Cancer Research, 12(1), 103. [More Information]
  • Banks, E., Canfell, K. (2009). Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. American Journal of Epidemiology, 170(1), 24-28. [More Information]
  • Canfell, K., Banks, E., Moa, A., Beral, V. (2008). Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Medical Journal of Australia, 188(11), 641-644. [More Information]
  • Banks, E., Canfell, K., Reeves, G. (2008). HRT and breast cancer: recent findings in the context of the evidence to date. Women's Health, 4(5), 427-431. [More Information]
  • Canfell, K., Kang, Y., Clements, M., Moa, A., Beral, V. (2008). Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology. Journal of Medical Screening, 15(4), 188-198. [More Information]
  • Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]
  • Canfell, K., Sitas, F., Beral, V. (2006). Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Medical Journal of Australia, 185(9), 482-486. [More Information]
  • Canfell, K., Beral, V., Green, J., Cameron, R., Baker, K., Brown, A. (2006). The agreement between self-reported cervical smear abnormalities and screening programme records. Journal of Medical Screening, 13(2), 72-75. [More Information]
  • Canfell, K., Gray, W., Snijders, P., Murray, C., Tipper, S., Drinkwater, K., Beral, V. (2004). Factors predicting successful DNA recovery from archival cervical smear samples. Cytopathology, 15(5), 276-282. [More Information]
  • Canfell, K., Barnabas, R., Patnick, J., Beral, V. (2004). The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. British Journal of Cancer, 91(3), 530-536. [More Information]

2018

  • Canfell, K. (2018). Cervical screening in HPV-vaccinated populations. Climacteric, 21(3), 227-234. [More Information]
  • Wade, S., Weber, M., Caruana, M., Kang, Y., Marshall, H., Manser, R., Vinod, S., Rankin, N., Fong, K., Canfell, K. (2018). Estimating the cost-effectiveness of lung cancer screening with low dose computed tomography for high risk smokers in Australia. Journal of Thoracic Oncology, 13(8), 1094-1105. [More Information]
  • Lew, J., St John, D., Macrae, F., Emery, J., Ee, H., Jenkins, M., He, E., Grogan, P., Caruana, M., Sarfati, D., Canfell, K., et al (2018). Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. International Journal of Cancer, 143(2), 269-282. [More Information]
  • He, E., Lew, J., Egger, S., Banks, E., Ward, R., Beral, V., Canfell, K. (2018). Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. Preventive Medicine, 106, 185-193. [More Information]
  • Nair-Shalliker, V., Bang, A., Weber, M., Goldsbury, D., Caruana, M., Emery, J., Banks, E., Canfell, K., O'Connell, D., Smith, D. (2018). Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study. Scientific Reports, 8(1), 4261. [More Information]
  • Goldsbury, D., Yap, S., Weber, M., Veerman, L., Rankin, N., Banks, E., Canfell, K., O'Connell, D. (2018). Health services costs for cancer care in Australia: Estimates from the 45 and Up Study. PloS One, 13(7), 1-15. [More Information]
  • Xu, H., Egger, S., Velentzis, L., O'Connell, D., Banks, E., Darlington-Brown, J., Canfell, K., Sitas, F. (2018). Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30�44 years: A case-control study in New South Wales, Australia. Cancer Epidemiology, 55, 162-169. [More Information]
  • Yap, S., Goldsbury, D., Yap, M., Yuill, S., Rankin, N., Weber, M., Canfell, K., O'Connell, D. (2018). Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: A population-based study. Lung Cancer, 122, 171-179. [More Information]
  • Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017�2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]
  • Canfell, K., Saville, M., Caruana, M., Gebski, V., Darlington-Brown, J., Brotherton, J., Heley, S., Castle, P. (2018). Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia. BMJ Open, 8(1), 1-13. [More Information]

2017

  • Hammond, I., Canfell, K., Saville, M. (2017). A new era for cervical screening in Australia: Watch this space!. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(5), 499-501. [More Information]
  • Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J., Gertig, D., Jennett, C., Farnsworth, A., Tan, J., et al (2017). Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PLoS Medicine, 14(9), 1-21. [More Information]
  • Lew, J., Simms, K., Smith, M., Saville, M., Hammond, I., Canfell, K. (2017). Cost-effectiveness estimates: the need for complete reporting � Authors' reply. The Lancet Public Health, 2(5), e212. [More Information]
  • Wentzensen, N., Arbyn, M., Berkhof, J., Bower, M., Canfell, K., Einstein, M., Farley, C., Monsonego, J., Franceschi, S. (2017). Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice. International Journal of Cancer, 140(10), 2192-2200. [More Information]
  • Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
  • Weber, M., Yap, S., Goldsbury, D., Manners, D., Tammemagi, M., Marshall, H., Brims, F., McWilliams, A., Fong, K., Kang, Y., Canfell, K., et al (2017). Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool. International Journal of Cancer, 141(2), 242-253. [More Information]
  • Goldsbury, D., Weber, M., Yap, S., Banks, E., O'Connell, D., Canfell, K. (2017). Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study. BMC Medical Informatics and Decision Making, 17(1), 1-10. [More Information]
  • Smith, M., Edwards, S., Canfell, K. (2017). Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985�2013 in all women and in Maori women. Cancer Causes and Control, 28(12), 1393-1404. [More Information]
  • Lew, J., St John, D., Xu, X., Greuter, M., Caruana, M., Cenin, D., He, E., Saville, A., Grogan, P., Coupe, V., Canfell, K. (2017). Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: A modelling study. The Lancet Public Health, 2(7), e331-e340. [More Information]
  • Velentzis, L., Salagame, U., Canfell, K. (2017). Menopausal hormone therapy: A systematic review of cost-effectiveness evaluations. BMC Health Services Research, 17(1), 1-15. [More Information]
  • Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
  • Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]
  • Smith, M., Canfell, K. (2017). Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia. Papillomavirus Research, 3, 134-141. [More Information]
  • Arriaga, M., Vajdic, C., Canfell, K., Macinnis, R., Hull, P., Magliano, D., Banks, E., Giles, G., Cumming, R., Byles, J., Hirani, V., Mitchell, P., et al (2017). The burden of cancer attributable to modifiable risk factors: The Australian cancer-PAF cohort consortium. BMJ Open, 7(6), 1-14. [More Information]
  • Kang, Y., Smith, M., Barlow, E., Coffey, K., Hacker, N., Canfell, K. (2017). Vulvar cancer in high-income countries: Increasing burden of disease. International Journal of Cancer, 141(11), 2174-2186. [More Information]

2016

  • Whop, L., Baade, P., Garvey, G., Cunningham, J., Brotherton, J., Lokuge, K., Valery, P., O'Connell, D., Canfell, K., Diaz, A., et al (2016). Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011. PloS One, 11(4), 1-12. [More Information]
  • Canfell, K., Saville, A., Hammond, I., Roeske, L. (2016). Changes to the cervical cancer screening program in Australia. Medicine Today, 17(5), 59-62.
  • Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
  • Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
  • Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
  • Smith, M., Canfell, K. (2016). Impact of the Australian national cervical screening program in women of different ages. Medical Journal of Australia, 205(8), 359-364. [More Information]
  • Salagame, U., Banks, E., Sitas, F., Canfell, K. (2016). Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study. International Journal of Cancer, 138(8), 1905-1914. [More Information]
  • Coffey, K., Gaitskell, K., Beral, V., Canfell, K., Green, J., Reeves, G., Barnes, I. (2016). Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women. British Journal of Cancer, 115(5), 599-606. [More Information]
  • Greuter, M., Berkhof, J., Canfell, K., Lew, J., Dekker, E., Coupe, V. (2016). Resilience of a FIT screening programme against screening fatigue: a modelling study. BMC Public Health, 16(1), 1-8. [More Information]
  • Whop, L., Garvey, G., Baade, P., Cunningham, J., Lokuge, K., Brotherton, J., Valery, P., O'Connell, K., O'Connell, D., Canfell, K., et al (2016). The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011). Cancer, 122(10), 1560-1569. [More Information]
  • Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2016). Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: Analysis of national hospital data. BMC Infectious Diseases, 16(1), 1-11. [More Information]
  • Velentzis, L., Banks, E., Sitas, F., Salagame, U., Tan, E., Canfell, K. (2016). Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study. PloS One, 11(3), 1-12. [More Information]
  • Whop, L., Diaz, A., Baade, P., Garvey, G., Cunningham, J., Brotherton, J., Canfell, K., Valery, P., O'Connell, D., Taylor, C., et al (2016). Using probabilistic record linkage methods to identify Australian Indigenous women on the Queensland Pap smear register: The national Indigenous cervical screening project. BMJ Open, 6(2), 1-10. [More Information]
  • Simms, K., Smith, M., Lew, J., Kitchener, H., Castle, P., Canfell, K. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International Journal of Cancer, 139(12), 2771-2780. [More Information]

2015

  • Simonella, L., Canfell, K. (2015). Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries. Vaccine, 33(1), 34-51. [More Information]
  • Kang, Y., O'Connell, D., Lotocki, R., Kliewer, E., Goldsbury, D., Demers, A., Canfell, K. (2015). Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada. BMC Cancer, 15(1), 1-10. [More Information]
  • Canfell, K., Egger, S., Velentzis, L., Brown, J., O'Connell, D., Banks, E., Sitas, F. (2015). Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. Vaccine, 33(20), 2387-2394. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2015). Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data. The Journal of Infectious Diseases, 211(1), 91-99. [More Information]
  • Canfell, K. (2015). HPV vaccination and pregnancy. BMJ, 351, 1-2. [More Information]
  • Kang, Y., O'Connell, D., Tan, J., Lew, J., Demers, A., Lotocki, R., Kliewer, E., Hacker, N., Jackson, M., Delaney, G., et al (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology, 39(4), 600-611. [More Information]
  • Sitas, F., Yap, S., Egger, S., Christian, K., Hodgkinson, V., Barton, M., Banks, E., Canfell, K., O'Connell, D., Nair-Shalliker, V. (2015). The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia. Cancer Epidemiology, 39(3), 414-423. [More Information]
  • Canfell, K. (2015). Who should be vaccinated against HPV? BMJ, 350, 1-2. [More Information]

2014

  • Simonella, L., Howard, K., Canfell, K. (2014). A survey of population-based utility scores for cervical cancer prevention. BMC Research Notes, 7(1), 1-11. [More Information]
  • Caruana, M., Kang, Y., Smith, D., O'Connell, D., Canfell, K. (2014). Estimating the benefits and harms of PSA testing in the Australian context. Cancer Forum, 38(3), 221-223.
  • Velentzis, L., Sitas, F., O'Connell, D., Darlington-Brown, J., Egger, S., Sinha, R., Banks, E., Frazer, I., Canfell, K. (2014). Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study. BMC Infectious Diseases, 14, 1-10. [More Information]
  • Smith, M., Canfell, K. (2014). Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake. PloS One, 9(8), 1-10. [More Information]
  • Smith, M., Canfell, K. (2014). Testing previous model predictions against new data on human papillomavirus vaccination program outcomes. BMC Research Notes, 7(1), 1-5. [More Information]

2013

  • Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
  • Simonella, L., Canfell, K. (2013). Erratum to: The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England. Cancer Causes and Control, 24(11), 2035. [More Information]
  • Shafer, L., Jeffrey, I., Elias, B., Shearer, B., Canfell, K., Kliewer, E. (2013). Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model. Vaccine, 31(42), 4848-4855. [More Information]
  • Simonella, L., Canfell, K. (2013). The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England. Cancer Causes and Control, 24(9), 1727-1736. [More Information]
  • Simonella, L., Lewis, H., Smith, M., Neal, H., Bromhead, C., Canfell, K. (2013). Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infectious Diseases, 13(1), 1-10. [More Information]
  • Aminisani, N., Armstrong, B., Canfell, K. (2013). Uptake of liquid-based cytology as an adjunct to conventional cytology for cervical screening in NSW, Australia: A cross-sectional and population-based cohort analysis. BMC Public Health, 13(1), 1-7. [More Information]

2012

  • Walker, R., Nickson, C., Lew, J., Smith, M., Canfell, K. (2012). A revision of sexual mixing matrices in models of sexually transmitted infection. Statistics in Medicine, 31(27), 3419-3432. [More Information]
  • Aminisani, N., Armstrong, B., Canfell, K. (2012). Cervical cancer screening in Middle Eastern and Asian migrants to Australia: A record linkage study. Cancer Epidemiology, 36(6), e394-e400. [More Information]
  • Legood, R., Smith, M., Lew, J., Walker, R., Moss, S., Kitchener, H., Patnick, J., Canfell, K. (2012). Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ: British Medical Journal, 345, 1-10. [More Information]
  • Shi, J., Chen, J., Canfell, K., Feng, X., Ma, J., Zhang, Y., Zhao, F., Li, R., Ma, L., Li, Z., et al (2012). Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study. BMC Health Services Research, 12(1), 1-14. [More Information]
  • Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
  • Aminisani, N., Armstrong, B., Egger, S., Canfell, K. (2012). Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia. BMC Cancer, 12(1), 1-10. [More Information]
  • Urban, M., Banks, E., Egger, S., Canfell, K., O'Connell, D., Beral, V., Sitas, F. (2012). Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African women: Case-Control study. PLoS Medicine, 9(3), 1-11. [More Information]
  • Canfell, K., Chesson, H., Kulasingam, S., Berkhof, J., Diaz, M., Kim, J. (2012). Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries. Vaccine, 30S(Supp 5), F157-F167. [More Information]
  • Shi, J., Canfell, K., Lew, J., Qiao, Y. (2012). The burden of cervical cancer in China: Synthesis of the evidence. International Journal of Cancer, 130(3), 641-652. [More Information]

2011

  • Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
  • Canfell, K., Shi, J., Lew, J., Walker, R., Zhoa, F., Simonella, L., Chen, J., Legood, R., Smith, M., Nickson, C., et al (2011). Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29(13), 2487-2494. [More Information]
  • Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]

2010

  • Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]
  • Canfell, K. (2010). Models of cervical screening in the era of human papillomavirus vaccination. Sexual Health, 7(3), 359-367. [More Information]
  • Canfell, K. (2010). Monitoring HPV vaccination programmes. BMJ, 340, c1666. [More Information]
  • Canfell, K., Banks, E. (2010). Oral Contraceptives, Hormone Replacement Therapy, and Cancers of the Female Reproductive System. In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 111-130). London: Imperial College Press. [More Information]
  • Banks, E., Canfell, K. (2010). Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible. Breast Cancer Research, 12(1), 103. [More Information]

2009

  • Banks, E., Canfell, K. (2009). Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. American Journal of Epidemiology, 170(1), 24-28. [More Information]

2008

  • Canfell, K., Banks, E., Moa, A., Beral, V. (2008). Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Medical Journal of Australia, 188(11), 641-644. [More Information]
  • Banks, E., Canfell, K., Reeves, G. (2008). HRT and breast cancer: recent findings in the context of the evidence to date. Women's Health, 4(5), 427-431. [More Information]
  • Canfell, K., Kang, Y., Clements, M., Moa, A., Beral, V. (2008). Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology. Journal of Medical Screening, 15(4), 188-198. [More Information]
  • Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]

2006

  • Canfell, K., Sitas, F., Beral, V. (2006). Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Medical Journal of Australia, 185(9), 482-486. [More Information]
  • Canfell, K., Beral, V., Green, J., Cameron, R., Baker, K., Brown, A. (2006). The agreement between self-reported cervical smear abnormalities and screening programme records. Journal of Medical Screening, 13(2), 72-75. [More Information]

2004

  • Canfell, K., Gray, W., Snijders, P., Murray, C., Tipper, S., Drinkwater, K., Beral, V. (2004). Factors predicting successful DNA recovery from archival cervical smear samples. Cytopathology, 15(5), 276-282. [More Information]
  • Canfell, K., Barnabas, R., Patnick, J., Beral, V. (2004). The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. British Journal of Cancer, 91(3), 530-536. [More Information]

To update your profile click here. For support on your academic profile contact .